Skip to main content

Table 1 Baseline characteristics and primary outcomes

From: Effects of phototherapy combined with Lactobacillus salivarius AP-32 or Bifidobacterium animalis subsp. lactis CP-9 on improving neonatal jaundice and gut microbiome health: a randomized double-blind clinical study

 

AP-32 (N = 89)

CP-9 (N = 96)

Placebo (N = 92)

P-value

Gender (M/F)

46/43

41/55

51/41

0.198

BBW (g)

3069.96 ± 36.10

3087.29 ± 33.94

3097.54 ± 35.71

0.858

Delivery method (NSD/C/S)

65/24

76/20

77/15

0.214

Gestational age (weeks)

37.93 ± 0.12

37.99 ± 0.12

38.08 ± 0.12

0.702

Baseline serum bilirubin (mg/dL)

15.84 ± 0.25

16.08 ± 0.23

15.67 ± 0.23

0.466

Endpoint serum bilirubin (mg/dL)

11.00 ± 0.15

11.21 ± 0.14

10.99 ± 0.14

0.464

Duration of hospital stay (hours)

57.06 ± 2.05*

62.34 ± 2.12

64.30 ± 2.51

0.066

Δ Jaundice index (mg/dL)

−4.84 ± 0.27

−4.88 ± 0.25

−4.68 ± 0.27

0.859

  1. Abbreviations: BBW, Birth body weight; NSD, Normal spontaneous delivery; C/S, Cesarean section
  2. *Significant difference between placebo, P < 0.05
  3. Δ Jaundice index = Endpoint serum bilirubin − Baseline serum bilirubin